Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Retrospective, Single Center Study of Clinical, Paraclinical and Natural Course of Infantile-Onset Pompe Disease

Noormohammad Noori 1 , Ghasem Miri Aliabad 1 , * and Ali Khajeh 1
Authors Information
1 Department of Pediatrics, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: January 28, 2015, 17 (1); e1939
  • Published Online: June 25, 2013
  • Article Type: Case Report
  • Received: March 1, 2013
  • Accepted: May 20, 2013

To Cite: Noori N, Miri Aliabad G, Khajeh A. Retrospective, Single Center Study of Clinical, Paraclinical and Natural Course of Infantile-Onset Pompe Disease, Zahedan J Res Med Sci. 2015 ; 17(1):e1939.

Copyright © 2015, Zahedan University of Medical Sciences. All rights reserved.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Materials and Methods
  • 1. Jones HN, Muller CW, Lin M, Banugaria SG, Case LE, Li JS, et al. Oropharyngeal dysphagia in infants and children with infantile Pompe disease. Dysphagia. 2010; 25(4): 277-83[DOI][PubMed]
  • 2. Kliegman R, Stanton B, St. Geme J. Nelson text book of pediatrics. 2011; : 499-500
  • 3. van Gijn J, Gijselhart JP. [Pompe and his disease]. Ned Tijdschr Geneeskd. 2011; 155[PubMed]
  • 4. Hirschhorn R, Reuser AJ. The Metabolic and molecular bases of inherited disease. 2001; : 3389-420
  • 5. Goldstein JL, Young SP, Changela M, Dickerson GH, Zhang H, Dai J, et al. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve. 2009; 40(1): 32-6[DOI][PubMed]
  • 6. Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr. 2000; 137(2): 283-5[DOI][PubMed]
  • 7. van der Ploeg AT, Reuser AJ. Pompe's disease. Lancet. 2008; 372(9646): 1342-53[DOI][PubMed]
  • 8. Kemper AR, Hwu WL, Lloyd-Puryear M, Kishnani PS. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations. Pediatrics. 2007; 120(5)-34[DOI][PubMed]
  • 9. Di Rocco M, Buzzi D, Taro M. Glycogen storage disease type II: clinical overview. Acta Myol. 2007; 26(1): 42-4[PubMed]
  • 10. Acmg Work Group on Management of Pompe Disease , Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006; 8(5): 267-88[PubMed]
  • 11. Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L, et al. Diagnosis of glycogenosis type II. Neurology. 2008; 71(23 Suppl 2)-11[DOI][PubMed]
  • 12. Umapathysivam K, Hopwood JJ, Meikle PJ. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem. 2001; 47(8): 1378-83[PubMed]
  • 13. van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003; 112(2): 332-40[PubMed]
  • 14. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D, et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006; 148(5): 671-6[DOI][PubMed]
  • 15. Willemsen MA, Jira PE, Gabreels FJ, van der Ploeg AT, Smeitink JA. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease]. Ned Tijdschr Geneeskd. 1998; 142(24): 1388-92[PubMed]
  • 16. Marsden D. Infantile onset Pompe disease: a report of physician narratives from an epidemiologic study. Genet Med. 2005; 7(2): 147-50[PubMed]
  • 17. Zhang HB, Zhang WM, Qiu JJ, Meng Y, Qiu ZQ. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease]. Zhonghua Er Ke Za Zhi. 2012; 50(6): 415-9[PubMed]
  • 18. Byrne BJ, Kishnani PS, Case LE, Merlini L, Muller-Felber W, Prasad S, et al. Pompe disease: design, methodology, and early findings from the Pompe Registry. Mol Genet Metab. 2011; 103(1): 1-11[DOI][PubMed]
  • 19. Levine JC, Kishnani PS, Chen YT, Herlong JR, Li JS. Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease. Pediatr Cardiol. 2008; 29(6): 1033-42[DOI][PubMed]
  • 20. Haskins M. Gene therapy for lysosomal storage diseases (LSDs) in large animal models. ILAR J. 2009; 50(2): 112-21[PubMed]
  • 21. Koeberl DD, Kishnani PS, Chen YT. Glycogen storage disease types I and II: treatment updates. J Inherit Metab Dis. 2007; 30(2): 159-64[DOI][PubMed]
  • 22. Sun B, Zhang H, Franco LM, Young SP, Schneider A, Bird A, et al. Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II. Mol Ther. 2005; 11(1): 57-65[DOI][PubMed]
  • 23. Pascual SI. Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme. Adv Exp Med Biol. 2009; 652: 39-46[DOI][PubMed]
  • 24. Chien YH, Chiang SC, Zhang XK, Keutzer J, Lee NC, Huang AC, et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics. 2008; 122(1)-45[DOI][PubMed]
  • 25. van der Beek NA, Hagemans ML, van der Ploeg AT, Reuser AJ, van Doorn PA. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. Acta Neurol Belg. 2006; 106(2): 82-6[PubMed]
  • 26. Leslie N, Tinkle BT. Gene Reviews™ [Internet]. 1993;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments